Skip to main content

OXYGENTAPH · OXYGENTA PHARMACEUTICAL LIMITE · Financials

50.77 INR +2.32 (+4.79%) At close · Nov 13
Market Cap
1.88B INR
Shares
36.98M
Volume · Nov 13 6751 Avg daily vol (3M) 13.33K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
1.13B +3.4%
FY2026 Revenue FY2025–FY2026
Net Income
-175.72M -70.6%
FY2026 Net Income FY2025–FY2026
Operating Cash Flow
-277.53M -1166.3%
FY2026 Operating Cash Flow FY2025–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025
INR 1.54B 1.13B 1.09B
INR 19.5M 23.23M 17.82M
INR 83.88M 47.77M 36.14M
INR -135.09M -221.8M -143.51M
INR -21.23M -46.09M -40.53M
INR -113.86M -175.72M -102.98M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.